The recently published 'Cass Review' in the UK has led the country's National Health Services to issue the decision that puberty-suppressing hormones will no longer be prescribed to minors. This decision has been met with mixed reactions and questions asking how the UK's stance on transgender care will affect the rest of the world.
From the start of President Trump’s “Liberation Day” and the subsequent tariff imposition on the European Union (EU), Europe has faced multiple rounds of...